20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T63239 | FXa-IN-1 | ||
FXa-IN-1 is an FXa inhibitor with an IC50 value of 3 nM and a Ki value of 0.7 nM that exhibits good oral bioavailability and half-life (in vivo) and can be used to study thromboembolic diseases. | |||
T10174 | 5-R-Rivaroxaban | Factor Xa | |
5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban. Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct Factor Xa (FXa) inhibitor (IC50 0.7 nM; Ki 0.4 nM). | |||
T4980 | Betrixaban maleate | Factor Xa | |
Betrixaban maleate is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa. | |||
T4341 | Betrixaban | PRT054021 | Factor Xa |
Betrixaban (PRT054021) is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa [1]. It was selected among all lead compounds due to its low hERG channel ... | |||
T0372 | Gabexate mesylate | FOY | Factor Xa , Serine Protease , Proteasome |
Gabexate mesylate (FOY) is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inh... | |||
T1184 | Rivaroxaban | BAY 59-7939 | Factor Xa , Thrombin |
Rivaroxaban (BAY 59-7939) is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both ... | |||
T1736 | Apixaban | BMS-562247-01 | Factor Xa |
Apixaban (BMS-562247-01) is an orally active inhibitor of coagulation factor Xa with anticoagulant activity. Apixaban directly inhibits factor Xa, thereby interfering with the conversion of prothrombin to thrombin and pr... | |||
T22323 | Enoxaparin sodium | Thrombin | |
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percu... | |||
T31206 | Darexaban | YM 150,Darexaban, Tanexaban,YM150 | Factor Xa |
Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothrombin activity at the site of blood clot (thrombus) formati... | |||
T4076 | Fondaparinux sodium | Natural heparin pentasaccharide Sodium,Fondaparin sodium,SR-90107A,Arixtra | Factor Xa |
Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity. | |||
T2368 | Edoxaban Tosylate Monohydrate | DU-176b,DU-176b tosylate Monohydrate,Lixiana,Edoxaban | Factor Xa , Thrombin |
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. | |||
T4690 | Betrixaban hydrochloride(330942-05-7(free base)) | PRT054021 hydrochloride | Factor Xa |
Betrixaban hydrochloride(330942-05-7(free base)) (PRT054021 hydrochloride) is a potent, selective, and orally efficacious factor Xa (fXa) inhibitor (IC50: 1.5 nM). | |||
T29215 | Zifaxaban | TY 602,TY602,TY-602 | Factor Xa |
Zifaxaban (TY-602) is an orally active, competitive and selective inhibitor of factor Xa (FXa) with an IC50 of 11.1 nM for human FXa.Zifaxaban has a very high affinity, more than 10,000-fold higher than that of other ser... | |||
T78215 | Dechloro Rivaroxaban | Factor Xa , Others | |
Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.Dechloro Rivaroxaban also has an inhibitory effect on throm... | |||
T2368L | Edoxaban | Lixiana | Factor Xa , Thrombin |
Edoxaban (Lixiana) (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with K i s of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and is a... | |||
T77373 | Concizumab | mAb 2021,NN 7415 | Others |
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, thereby blocking the interaction of this domain with the FXa active site. Injecti... | |||
T27318 | Fidexaban | CI-1031,BX-807834,PD-200022,CI1031,BX807834,ZK-807834 | Factor Xa |
Fidexaban (CI1031) is a novel, potent, selective and orally active factor Xa inhibitor that has demonstrated antithrombotic activity in a variety of assays | |||
T12736 | Rivaroxaban-d4 | BAY 59-7939 D4 | Factor Xa |
Rivaroxaban D4 is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct inhibitor of Factor Xa (FXa)(IC50:0.7 nM; Ki:0.4 nM). | |||
T27224 | DX-9065A HCl hydrate | DX9065,DX 9065,DX9065A,DX 9065A,DX-9065A,DX-9065 | |
DX-9065A is a factor Xa inhibitor. DX-9065a inhibits proinflammatory events induced by factor Xa and gingipains. DX-9065a is a competitive inhibitor of the Spectrozyme FXa (SpFXa) cleavage by both fXa and prothrombinase ... | |||
T16410 | Otamixaban | FXV673 | Others |
Otamixaban(FXV673) is an effective (Ki = 0.5 nM), selective, rapid-acting, competitive, and reversible fXa inhibitor. It also effectively inhibits both free and prothrombinase-bound fXa. |